Description

Lazolvan Tablets 30 mg. №50

Ingredients:

Each tablet contains 30 mg of ambroxol hydrochloride as the active ingredient.

Dosage:

The usual dose for adults and children over 12 years old is one tablet three times a day.

Indications:

Lazolvan tablets are indicated for the treatment of respiratory diseases associated with viscid mucus, such as acute and chronic bronchitis, bronchial asthma, and pneumonia.

Contraindications:

Do not use Lazolvan tablets in case of hypersensitivity to ambroxol or any other component of the product.

Directions:

Swallow the tablets whole with a sufficient amount of water. Do not crush or chew the tablets.

Scientific Evidence:

Ambroxol, the active ingredient in Lazolvan tablets, is a mucolytic agent that works by breaking down and thinning mucus in the airways, making it easier to cough up. Studies have shown that ambroxol enhances the production of surfactant in the lungs, improving mucociliary clearance and reducing the risk of respiratory infections.

Additional Information:

Lazolvan tablets have been extensively studied in clinical trials for their efficacy in respiratory conditions. Research has demonstrated that ambroxol not only helps in clearing mucus from the airways but also exhibits anti-inflammatory and antioxidant properties, which can be beneficial in the management of respiratory diseases.

Compared to other mucolytic agents, Lazolvan tablets have shown comparable efficacy with a favorable safety profile, making them a preferred choice for healthcare providers in the treatment of respiratory conditions.